Companies House does not verify the accuracy of the information filed

GLOX THERAPEUTICS LIMITED

Company number SC760230

Follow this company File for this company

Filter by category

Show filing type

Accounts Capital Charges

Confirmation statements / Annual returns Incorporation Officers

Date (document was filed at Companies House)	Type	Description (of the document filed at Companies House)	View / Download (PDF file, link opens in new window)
20 Nov 2024	PSC08	Notification of a person with significant control statement	View PDF Notification of a person with significant control statement - link opens in a new window - 2 pages (2 pages)
17 Sep 2024	AD01	Registered office address changed from , 11 the Square University of Glasgow, University Avenue, Glasgow, G12 8QQ, United Kingdom to John Arbuthnott Building Strathclyde University of Pharmacy & Biomedical 161 Cathedral Street Glasgow G4 0RE on 17 September 2024	View PDF Registered office address changed from , 11 the Square University of Glasgow, University Avenue, Glasgow, G12 8QQ, United Kingdom to John Arbuthnott Building Strathclyde University of Pharmacy & Biomedical 161 Cathedral Street Glasgow G4 0RE on 17 September 2024 - link opens in a new window - 1 page (1 page)
19 Aug 2024	TM01	Termination of appointment of Melville Anderson as a director on 19 August 2024	View PDF Termination of appointment of Melville Anderson as a director on 19 August 2024 - link opens in a new window - 1 page (1 page)
08 Aug 2024	AA	Accounts for a small company made up to 31 December 2023	View PDF Accounts for a small company made up to 31 December 2023 - link opens in a new window - 7 pages (7 pages)
22 Mar 2024	CS01	Confirmation statement made on 26 February 2024 with updates	View PDF Confirmation statement made on 26 February 2024 with updates - link opens in a new window - 4 pages (4 pages)
20 Feb 2024	AA01	Previous accounting period shortened from 28 February 2024 to 31 December 2023	View PDF Previous accounting period shortened from 28 February 2024 to 31 December 2023 - link opens in a new window - 1 page (1 page)
18 Jan 2024	AP01	Appointment of Dr Niklas Czeloth as a director on 24 October 2023	View PDF Appointment of Dr Niklas Czeloth as a director on 24 October 2023 - link opens in a new window - 2 pages (2 pages)
18 Jan 2024	AP01	Appointment of Professor Daniel Walker as a director on 24 October 2023	View PDF Appointment of Professor Daniel Walker as a director on 24 October 2023 - link opens in a new window - 2 pages (2 pages)
17 Jan 2024	SH01	Statement of capital following an allotment of shares on 24 October 2023 GBP 156.14	View PDF Statement of capital following an allotment of shares on 24 October 2023 GBP 156.14 - link opens in a new window - 4 pages (4 pages)
17 Jan 2024	PSC07	Cessation of Daniel Walker as a person with significant control on 24 October 2023	View PDF Cessation of Daniel Walker as a person with significant control on 24 October 2023 - link opens in a new window - 2 pages (2 pages)
09 Jan 2024	RESOLUTIONS	Resolutions RES10 ‐ Resolution of allotment of securities RES11 ‐ Resolution of removal of pre-emption rights RES01 ‐ Resolution of adoption of Articles of Association	View PDF Resolutions RES10 ‐ Resolution of allotment of securities RES11 ‐ Resolution of removal of pre-emption rights RES01 ‐ Resolution of adoption of Articles of Association - link opens in a new window - 2 pages (2 pages)
09 Jan 2024	MA	Memorandum and Articles of Association	View PDF Memorandum and Articles of Association - link opens in a new window - 67 pages (67 pages)
16 May 2023	RESOLUTIONS	Resolutions RES10 ‐ Resolution of allotment of securities RES01 ‐ Resolution of adoption of Articles of Association	View PDF Resolutions RES10 ‐ Resolution of allotment of securities RES01 ‐ Resolution of adoption of Articles of Association - link opens in a new window - 1 page (1 page)
16 May 2023	MA	Memorandum and Articles of Association	View PDF Memorandum and Articles of Association - link opens in a new window - 34 pages (34 pages)
16 May 2023	RESOLUTIONS	Resolutions RES10 ‐ Resolution of allotment of securities	View PDF Resolutions RES10 ‐ Resolution of allotment of securities - link opens in a new window - 1 page (1 page)
15 May 2023	PSC07	Cessation of Colin Kleanthous as a person with significant control on 13 April 2023	View PDF Cessation of Colin Kleanthous as a person with significant control on 13 April 2023 - link opens in a new window - 1 page (1 page)
15 May 2023	PSC07	Cessation of G U Holdings Limited as a person with significant control on 12 April 2023	View PDF Cessation of G U Holdings Limited as a person with significant control on 12 April 2023 - link opens in a new window - 1 page (1 page)
15 May 2023	PSC01	Notification of Colin Kleanthous as a person with significant control on 12 April 2023	View PDF Notification of Colin Kleanthous as a person with significant control on 12 April 2023 - link opens in a new window - 2 pages (2 pages)
15 May 2023	PSC01	Notification of Daniel Walker as a person with significant control on 12 April 2023	View PDF Notification of Daniel Walker as a person with significant control on 12 April 2023 - link opens in a new window - 2 pages (2 pages)
15 May 2023	SH01	Statement of capital following an allotment of shares on 13 April 2023 GBP 100	View PDF Statement of capital following an allotment of shares on 13 April 2023 GBP 100 - link opens in a new window - 3 pages (3 pages)
18 Apr 2023	MA	Memorandum and Articles of Association	View PDF Memorandum and Articles of Association - link opens in a new window - 34 pages (34 pages)
27 Feb 2023	NEWINC	Incorporation MODEL ARTICLES ‐ Model articles adopted Statement of capital on 2023-02-27 GBP 15.3	View PDF Incorporation MODEL ARTICLES ‐ Model articles adopted Statement of capital on 2023-02-27 GBP 15.3 - link opens in a new window - 12 pages (12 pages)

Cookies on Companies House services

GLOX THERAPEUTICS LIMITED

Filter by category